Allarity Therapeutics Balance Sheet Health
Financial Health criteria checks 6/6
Allarity Therapeutics has a total shareholder equity of $13.0M and total debt of $1.3M, which brings its debt-to-equity ratio to 10.3%. Its total assets and total liabilities are $20.4M and $7.4M respectively.
Key information
10.3%
Debt to equity ratio
US$1.34m
Debt
| Interest coverage ratio | n/a |
| Cash | US$18.46m |
| Equity | US$12.96m |
| Total liabilities | US$7.41m |
| Total assets | US$20.38m |
Recent financial health updates
Financial Position Analysis
Short Term Liabilities: ALLR's short term assets ($20.4M) exceed its short term liabilities ($7.4M).
Long Term Liabilities: ALLR has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: ALLR has more cash than its total debt.
Reducing Debt: ALLR's debt to equity ratio has reduced from 23.4% to 10.3% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: ALLR has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: ALLR has sufficient cash runway for 1.1 years if free cash flow continues to reduce at historical rates of 15.1% each year.